MediciNova, Inc.
MNOVDrugs in Pipeline
6
Phase 3 Programs
1
Upcoming Catalysts
3
Next Catalyst
Aug 13, 2026
10dMarket Overview
Stock performance and key metrics
3 upcoming, 0 past
MNOV Earnings Report
EPS Est: $-0.06 | FQ end 2026-06
2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How MNOV's past catalysts played out
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in MediciNova, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in MediciNova, Inc.'s (MNOV) pipeline across Phase 3, Phase 2. Its lead program is MN-166 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MediciNova, Inc.'s next FDA catalyst?→
MediciNova, Inc.'s (MNOV) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MNOV biotech catalysts?→
Add MNOV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MediciNova, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.